Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification

Overview of attention for article published in Lung Cancer: Targets and Therapy, March 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Dove Medical Press, 07 Sep 2019

Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell…